General Statement of Disclosure:

CONSULTING FEES/HONORARIA: UpToDate(SIGNIFICANT), Astellas Pharma US(MODEST), Alnylam(MODEST) RESEARCH/RESEARCH GRANTS: Ultromics(SIGNIFICANT), Edwards Lifesciences(MODEST), Lantheus(MODEST)

View Full Disclosure